Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patients
This study demonstrated that AChR-ab positive VLOMG patients have a favorable prognosis and responded well to medication, with age and comorbidities showing no significant impact.
Authors
- Yuwei Da (ORCID: https://orcid.org/0000-0002-0318-148X)
- Xuxiang Zhang (ORCID: https://orcid.org/0000-0002-2833-0656)
- Wenjia Zhu (ORCID: https://orcid.org/0000-0003-1397-4544)
- Yaye Wang (ORCID: https://orcid.org/0000-0003-0505-3243)
- Xin‐Ming Shen (ORCID: https://orcid.org/0000-0002-7087-5166)
- Yuting Jiang (ORCID: https://orcid.org/0000-0001-7404-5250)
- Yan Lü (ORCID: https://orcid.org/0000-0001-5353-4362)
- Nairong Xie (ORCID: https://orcid.org/0009-0008-4616-2861)
- Haoran Liu (ORCID: https://orcid.org/0000-0001-8216-3679)
- Xinmei Wen
- Li Di (ORCID: https://orcid.org/0000-0001-6117-9022)
- Qi Wen (ORCID: https://orcid.org/0000-0002-5408-2123)
- Min Wang (ORCID: https://orcid.org/0000-0003-0841-2651)
- Qing Liu (ORCID: https://orcid.org/0000-0002-0427-1065)
Institutions
- Capital Medical University (CN)
- Mayo Clinic in Florida (US)
- Beijing Fengtai Hospital (CN)
Publication Details
- Journal
- Therapeutic Advances in Neurological Disorders
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17562864241309793
- Citations
- 5
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 6.95
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China